Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia.

Japanese journal of clinical oncology - 1 Aug 2015

Kagita Sailaja, Uppalapati Srihari, Gundeti Sadasivudu, Digumarti Raghunadharao

Abstract excerpt

OBJECTIVE: Altered differentiation is a common feature of haematopoietic malignancies with poor prognosis. CAAT/enhancer binding protein alpha (C/EBPα) is a key transcription factor that regulates myeloid differentiation. This study is aimed to know the prognostic value of CAAT/enhancer binding protein alpha expression and correlate its expression with response to imatinib therapy. METHODS: We quantified the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to CCAAT-Enhancer-Binding Protein-alpha

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fusion Proteins, bcr-abl

Share to Imatinib Mesylate

Share to Isoleucine

Share to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Share to Piperazines

Share to Threonine

Source

Identifiers

PMID: 25920395
DOI: 10.1093/jjco/hyv064

Genes

BCR

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Correlation of C/EBPα expression with response and resistance to imatinib in chronic myeloid leukaemia.PMID 25920395Read ↗

Regulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review)Semantic proximity Read ↗

Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation.Semantic proximity Read ↗

C/EBPα in normal and malignant myelopoiesis.Semantic proximity Read ↗

C/EBPα deregulation as a paradigm for leukemogenesis.Semantic proximity Read ↗

[Roles of CEBPA mutation and expression abnormality in acute myeloid leukemia - review].Semantic proximity Read ↗

[Transcription factor-based therapies for acute myeloid leukemia].Semantic proximity Read ↗

The gene signature in CCAAT-enhancer-binding protein α dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors.Semantic proximity Read ↗

C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemiaSemantic proximity Read ↗

C/EBPα dysregulation in AML and ALL.Semantic proximity Read ↗

Epigenetic Modification of CCAAT/Enhancer Binding Protein α Expression in Acute Myeloid LeukemiaSemantic proximity Read ↗

C/EBPα is an essential collaborator in Hoxa9/Meis1-mediated leukemogenesisSemantic proximity Read ↗

Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.